FDA Approves Lidocaine Transdermal System for Postherpetic Neuralgia Pain

The FDA approved a 1.8% lidocaine topical system (ZTlido, Scilex) for the relief of pain associated with postherpetic neuralgia (PHN), also referred to as post-shingles pain.

“Topical lidocaine is an important option for health care providers to have in their armamentarium for treating PHN, a difficult-to-treat neuropathic pain,” stated Jeff Gudin, MD, the director of pain management and palliative care at Englewood Hospital and Medical Center, in New Jersey, and a member of the Pain